Process for encapsulating soluble biologics, therapeutics, and imaging agents
US-11103461-B2 · Aug 31, 2021 · US
US11731099B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11731099-B2 |
| Application number | US-201916517510-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 19, 2019 |
| Priority date | Jul 20, 2018 |
| Publication date | Aug 22, 2023 |
| Grant date | Aug 22, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for controlling the encapsulation efficiency and burst release of water soluble molecules from nanoparticle and microparticle formulations produced by the inverted Flash NanoPrecipitation (iFNP) process and subsequent processing steps is presented. The processing steps and materials used can be adjusted to tune the encapsulation efficiency and burst release of the encapsulated water-soluble material. The encapsulation efficiency of the soluble agent in the particles and the burst release of the soluble agent from the particles can be controlled by: (1) the copolymers used in the assembly or coating process, (2) the degree of crosslinking of the nanoparticle core, (3) the incorporation of small molecule or polymeric additives, and/or (4) the processing and release conditions employed.
Opening claim text (preview).
The invention claimed is: 1. A method of forming a polymer inverse nanoparticle that encapsulates a water soluble active to maximize or optimize encapsulation efficiency and/or to mimimize or optimize burst fraction, comprising: dissolving the water soluble active at a concentration and a block copolymer at a concentration in an amount of a process solvent to form a process solution; and continuously mixing the process solution with an amount of a nonprocess solvent at a process temperature to form a first nanoparticle solution comprising polymer inverse nanoparticles having a core and a shell and a first nanoparticle solvent; adding a second block copolymer to the first nanoparticle solution to form a second stage process solution; and continuously mixing the second stage process solution with a finishing solvent to form a second nanoparticle solution comprising the polymer inverse nanoparticles coated with the second block copolymer, wherein the block copolymer comprises a hydrophilic block and a hydrophobic block having a glass transition temperature (Tg), wherein the hydrophilic block is soluble in the process solvent and is insoluble in the nonprocess solvent, wherein the hydrophobic block is insoluble in the process solvent and is soluble in the nonprocess solvent, wherein the process solution is more polar than the nonprocess solvent, wherein the water soluble active and the hydrophilic block are in the core and the hydrophobic block is in the shell, and wherein the encapsulation efficiency is maximized or optimized by (a) selecting the process solvent, so that the hydrophilic block is close to a solubility limit in the process solution for the concentration of the block copolymer, and/or (b) crosslinking the hydrophilic block in the core, and/or (c) selecting the hydrophilic block to have bonding interactions with the water soluble active in the core, and/or (d) selecting the hydrophobic block to have a molecular weight of at least 10 kDa, 20 kDa, 30 kDa, 40 kDa, 50 kDa, 70 kDa, or 100 kDa, and/or (e) selecting the process temperature and/or the hydrophobic block, so that the process temperature is less than the hydrophobic block glass transition temperature (Tg), and/or (f) selecting the process solvent to have high osmolarity, and/or (g) adding a supplemental hydrophobic compound to the process solvent and/or to the nonprocess solvent to increase the bulk of hydrophobic material in the shell, and/or wherein the burst fraction is minimized or optimized by (aa) crosslinking the hydrophilic block in the core, and/or (bb) increasing the hydrophobic block glass transition temperature (Tg), and/or (cc) adding the supplemental hydrophobic compound to the process solvent and/or to the nonprocess solvent to increase the bulk of hydrophobic material in the shell, and wherein the second block copolymer comprises a second hydrophilic block and a second hydrophobic block. 2. The method of claim 1 , wherein the second hydrophilic block is selected from the group consisting of poly(ethylene glycol) and poly(propylene oxide) and wherein the second hydrophobic block is selected from the group consisting of poly(lactic acid), poly(lactic-co-glycolic acid), and poly(caprolactone). 3. The method of claim 2 , wherein the encapsulation efficiency is maximized by adding the supplemental hydrophobic compound to the nonprocess solvent to increase the bulk of hydrophobic material in the shell, wherein the burst fraction is minimized by adding the supplemental hydrophobic compound to the nonprocess solvent to increase the bulk of hydrophobic material in the shell, and wherein the supplemental hydrophobic compound is selected from the group consisting of a hydrophobic polymer, polylactic acid, vitamin E, and combinations. 4. The method of claim 2 , wherein the burst fraction is minimized by selecting the process temperature and/or the hydrophobic block, so that the process temperature is less than the hydrophobic block glass transition temperature (Tg). 5. The method of claim 2 , further comprising annealing the polymer inverse nanoparticle, wherein the annealing maximizes the encapsulation efficiency and wherein the annealing optimizes the encapsulation efficiency. 6. The method of claim 2 , wherein the water soluble active is selected from the group consisting of a linear polypeptide, a cyclic polypeptide, ovalbumin, lysozyme, PEP1, and vancomycin. 7. The method of claim 2 , wherein the hydrophilic block is selected from the group consisting of poly(aspartic acid) and poly(glutamic acid) and wherein the hydrophobic block is selected from the group consisting of poly(lactic acid), poly(lactic-co-glycolic acid), and poly(caprolactone). 8. The method of claim 2 , wherein the hydrophilic block is of a molecular weight in the range of from 0.2 kDa to 100 kDa, from 0.5 kDa to 50 kDa, from 1 kDa to 20 kDa, from 2 kDa to 10 kDa, or of about 5 kDa, and wherein the hydrophobic block is of a molecular weight in the range of from 0.5 kDa to 400 kDa, 1 kDa to 200 kDa, from 2 kDa to 100 kDa, from 5 kDa to 100 kDa, from 10 kDa to 40 kDa, of about 10 kDa, of about 20 kDa, or of about 40 kDa. 9. The method of claim 2 , wherein the supplemental hydrophobic compound is selected from the group consisting of poly(lactic acid), poly(lactic-co-glycolic acid), and poly(caprolactone). 10. The method of claim 2 , wherein the process solvent is miscible with the nonprocess solvent. 11. The method of claim 2 , wherein the encapsulation efficiency is optimized by crosslinking the hydrophilic block in the core, wherein the burst fraction is minimized by crosslinking the hydrophilic block in the core, and wherein the crosslinking agent is selected from the group consisting of a metal, calcium, a chelating agent, tetraethylene pentamine (TEPA), and combinations. 12. The method of claim 2 , wherein the second hydrophilic block is of a molecular weight in the range of from 0.2 kDa to 100 kDa, from 0.5 kDa to 50 kDa, from 1 kDa to 20 kDa, from 2 kDa to 10 kDa, or of about 5 kDa and wherein the second hydrophobic block is of a molecular weight in the range of from 0.2 kDa to 100 kDa, from 0.5 kDa to 50 kDa, from 1 kDa to 20 kDa, from 2 kDa to 10 kDa, or of about 5 kDa. 13. The method of claim 2 , wherein the second stage process solution is miscible with the finishing solvent. 14. The method of claim 2 , wherein the water soluble active is anionic and the hydrophilic block is selected to be cationic, so that the water soluble active and the hydrophilic block ionically bond or wherein the water soluble active is cationic and the hydrophilic block is selected to be anionic, so that the water soluble active and the hydrophilic block ionically bond. 15. The method of claim 2 , further comprising adding a tackifier to the process solvent and/or to the nonprocess solvent to increase the hydrophobic block glass transition temperature (Tg). 16. The method of claim 2 , wherein the process solvent and the finishing solvent are each independently selected from the group consisting of dimethylsulfoxide (DMSO), propanol, ethanol, methanol, water, and combinations and wherein the nonprocess solvent is selected from the group consisting of dichloromethane, chloroform, acetone, tetrahydrofuran (THF), methanol, and combinations. 17. The method of claim 2 , wherein the continuous mixing is through a flash nanoprecipitation process. 18. The method of claim 1 , wherein the process solvent is selected to have high osmolarity by dissolving a salt in the proce
Applications of microcapsules not provided for in other subclasses · CPC title
Polymerisation; cross-linking · CPC title
Coating · CPC title
containing polyether sequences · CPC title
containing polyester or polycarbonate sequences · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.